Acknowledgments
We thank the internal medicine department at Hamad Medical Corporation for giving us the opportunity and support to conduct this work.
Authors Contribution:Ahmad S matarneh: History and physical examination, literature review, manuscript writing Alia Al battah: History and physical examination, literature review, manuscript writing Khalid farooqui Literature review, manuscript writing Mohammed ghamoodi: Clinical Care Mohammed Alhatou: clinical care, manuscript writing, literature review and mentor
References
  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal of medical virology. 2020 Apr;92(4):401.
  2. Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biological procedures online. 2020 Dec;22:1-0.
  3. Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). StatPearls. 2021 Apr 20.
  4. Yan ZP, Yang M, Lai CL. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals. 2021 May;14(5):406.
  5. Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nature medicine. 2021 Feb;27(2):205-11.
  6. Lu L, Xiong W, Mu J, Zhang Q, Zhang H, Zou L, Li W, He L, Sander JW, Zhou D. Neurological side effects of COVID‐19 vaccines are rare. Acta Neurologica Scandinavica. 2021 Jul;144(1):111.
  7. Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica chimica acta. 2020 Sep 1;508:254-66.
  8. Yuan P, Ai P, Liu Y, Ai Z, Wang Y, Cao W, Xia X, Zheng JC. Safety, tolerability, and immunogenicity of COVID-19 vaccines: a systematic review and meta-analysis. medRxiv. 2020 Jan 1.
  9. Anand P, Stahel VP. Review the safety of Covid-19 mRNA vaccines: a review. Patient safety in surgery. 2021 Dec;15(1):1-9.
  10. Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. Journal of Clinical Neuroscience. 2008 Dec 1;15(12):1315-22.
  11. Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. International Journal of Infectious Diseases. 2021 May 1;106:376-81.
  12. Goss AL, Samudralwar RD, Das RR, Nath A. ANA investigates: neurological complications of COVID‐19 vaccines. Annals of neurology. 2021 May;89(5):856-7.
  13. Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and guillain-barre syndrome. Drug Safety. 2009 Apr;32(4):309-23.
  14. Lunn MP, Cornblath DR, Jacobs BC, Querol L, van Doorn PA, Hughes RA, Willison HJ. COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations. Brain. 2021 Feb;144(2):357-60.
15. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005 Nov 5;366(9497): 1653–66.
16 Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123-133. doi pubmed
17. Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology. 1998;51(4):1110-1115. doi pubmed
18. Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barre syndrome. Drug Saf. 2009;32(4):309-323. doi pubmed
19. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am J Epidemiol. 1979;110(2):105-123. doi pubmed
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination
more patients gain access to the coronavirus disease
2019 (COVID-19) vaccines, neurologists are facing
questions about potential neurological complications, ben-
ets, and timing of vaccination.